Boron One raises Serbia project economics in updated study
Original announcement by northernminer on
- Company
- Boron One Holdings
- Ticker
- BONE
- Exchange
- Unavailable
- Region
- Serbia
- Primary commodity
- Boron
- Secondary commodities
- None reported
- Document categories
- Other, Resource update
- Extracted
- 2026-10-14 16:47:05 UTC
Analysis by Minestarters Atlas
Atlas analysis published:
Minestarters Atlas analysis
Summary
Boron One Holdings has released an updated Preliminary Economic Assessment (PEA) for its Piskanja boron project in Serbia, forecasting an improved after-tax IRR of 89%. While the NPV has risen to $558.8 million, the projected mine life has decreased from 16 to 13 years.
Reasoning: The updated PEA shows improved project economics (IRR and NPV) despite a reduction in mine life and annual EBITDA.
Positive factors
- Significant increase in after-tax IRR from 79% to 89%
- NPV increased by 6% to $558.8 million
- Average annual gross revenue increased to $140.4 million
- Payback projected within one year of production
Negative factors
- Mine life reduced from 16 to 13 years
- Average annual EBITDA dropped from $91.3 million to $87.7 million
- Economic assessment excludes inferred resources
Facts used in scoring: 7
Classification and evidence
Resource Updateneutral
Revised estimate for an existing resource — compare to prior to assess progress.
Why it applies: The document provides an updated resource estimate for the Piskanja project.
Evidence · text
“Measured and indicated resources at Piskanja total 7.1 million tonnes grading 32.4% boron trioxide”
Extracted facts
Stored fact records: 0. Some facts used in scoring do not have a stored record.
No stored fact records are available for this extraction.
How Atlas produces this analysis
Minestarters Atlas uses automated extraction to summarize mining announcements, identify reported measurements, and classify supporting evidence. Sentiment reflects the extracted narrative and classification rules; it is an interpretation, not a reported measurement. Evidence quotes and context are provided where available. Missing data, low-confidence results, and review flags indicate limitations. Check the original publisher announcement before relying on an interpretation.